We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 2 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 2 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 04. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 02. 13. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2023. 08. 04. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2022. 07. 07. | Raymond James | — | Downgrade | Strong Buy → Outperform | — | Raymond James: Strong Buy → Outperform |
| 2022. 06. 02. | Janney Montgomery Scott | — | Downgrade | Buy → Neutral | — | Janney Montgomery Scott: Buy → Neutral |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.